Recruiting N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma NCT06528496 Conditions Childhood Neuroblastoma, High-risk Neuroblastoma, Neoplasms, +9 more Locations Memorial Sloan Kettering Cancer Center — New York, United States View Trial Details
